Laparoscopic repeat hepatectomy versus conventional open repeat hepatectomy for recurrent hepatocellular carcinoma: A systematic review and meta-analysis.

Front Oncol

Department of Liver Surgery and Liver Transplantation Centre, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.

Published: September 2022

Background: Repeat hepatectomy has been proven to be an effective treatment in patients with recurrent hepatocellular carcinoma (RHCC). However, for RHCC, it is still controversial whether laparoscopic hepatectomy is superior to conventional ones. The present meta-analysis was carried out to investigate the safety and overall effect of laparoscopic repeat hepatectomy (LRH) to open repeat hepatectomy (ORH) for patients with RHCC.

Methods: A meta-analysis was registered at PROSPERO, and the registration number is CRD42021257569. PubMed, Web of Science, and EMBASE were searched based on a defined search strategy to identify eligible studies before 25 April 2022. Data on operative times, bleeding volume, overall complications, 90-day mortality, blood transfusion, length of stay, overall survival rate, and long-term recurrence-free survival rate were subjected to meta-analysis.

Results: Overall, we identified nine studies of LRH versus ORH enrolling a total of 945 patients (460 and 485 underwent LRH and ORH, respectively). The present meta-analysis revealed non-significant differences in operative time, blood transfusion, overall complications, 90-day mortality, 3-year overall survival rate, 5-year overall survival rate, and long-term recurrence-free survival rate between the two groups. Alternatively, comparing LRH with ORH, LRH has less bleeding volume (p < 0.001) and a shorter length of stay (p = 0.005).

Conclusion: LRH is a feasible and effective treatment strategy for RHCC.

Systematic Review Registration: https://www.crd.york.ac.uk/PROSPERO/#searchadvanced, identifier CRD42021257569.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521539PMC
http://dx.doi.org/10.3389/fonc.2022.960204DOI Listing

Publication Analysis

Top Keywords

repeat hepatectomy
20
survival rate
20
laparoscopic repeat
8
open repeat
8
recurrent hepatocellular
8
hepatocellular carcinoma
8
effective treatment
8
bleeding volume
8
complications 90-day
8
90-day mortality
8

Similar Publications

Objective: The objective of this study was to develop and validate a clinically applicable nomogram for predicting the risk of delirium following hepatectomy.

Methods: We applied the LASSO regression model to identify the independent risk factors associated with POD. Subsequently, we utilized R software to develop and validate a nomogram model capable of accurately predicting the incidence of POD.

View Article and Find Full Text PDF

Objectives: This study aims to assess the feasibility and short-term and intermediate-term technical success rate of the concept of systematic selective hepatic vein (HV) reconstruction for parenchyma-sparing hepatectomies (PSHs) in patients with colorectal liver metastases (CRLM) in accordance with stage 2a of the IDEAL framework.

Design: The prospective case series of patients deemed eligible and operated on according to the concept.

Setting: All patients were treated by a single surgical team in three hospitals in Ukraine from June 2022 to November 2023.

View Article and Find Full Text PDF

Treatment-sequencing before and after index hepatectomy with either synchronous or metachronous colorectal liver metastasis: Comparison of recurrence risk, repeat hepatectomy and overall survival in a population-derived cohort.

Eur J Surg Oncol

December 2024

Department of Gastrointestinal Surgery, Stavanger University Hospital, Stavanger, Norway; Gastrointestinal Translational Research Group, Laboratory for Molecular Medicine, Stavanger University Hospital, Stavanger, Norway; Department of Clinical Medicine, University of Bergen, Bergen, Norway. Electronic address:

Background: Treatment of colorectal cancer liver metastasis (CRLM) includes several options with impact on the patient journey and may depend on presentation and patient characteristics. The aim of the study was to investigate how treatment sequencing in index hepatectomy for synchronous or metachronous CRLM may potentially impact treatment pathways and oncological outcomes.

Methods: An observational cohort study (ACROBATICC; NCT0176813) of patients having surgery for CRLM.

View Article and Find Full Text PDF
Article Synopsis
  • Laparoscopic myomectomy (LM) is prone to postoperative adhesions, leading to complications such as bowel obstruction, which emphasizes the need for anti-adhesion measures.
  • AdSpray™, a dextrin hydrogel launched in 2017, has not been widely studied in gynecology despite showing promise in other surgical fields; this study examines its effectiveness in LM.
  • In a report of 24 cases, only 16.7% had adhesions post-surgery, and there were no significant adverse effects linked to AdSpray™, suggesting it could be a useful option in preventing adhesions.
View Article and Find Full Text PDF
Article Synopsis
  • This study compares the effectiveness of repeat laparoscopic hepatectomy (r-LH) and radiofrequency ablation (RFA) in treating patients with recurrent hepatocellular carcinoma (RHCC) based on clinical outcomes and survival rates.
  • Data from 272 RHCC patients were analyzed, revealing that while RFA resulted in shorter hospital stays and fewer complications, r-LH significantly improved overall and disease-free survival rates.
  • Particularly, patients with solitary tumors or those located near critical structures benefitted more from r-LH, especially when tumors were 5 cm or smaller, suggesting it as a more favorable treatment option in these cases.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!